Ceftriaxone DALI Pharma 500 mg Powder for Solution for Injection Malta - English - Medicines Authority

ceftriaxone dali pharma 500 mg powder for solution for injection

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - ceftriaxone sodium - powder for solution for injection - ceftriaxone sodium 500 mg - antibacterials for systemic use

Ceftriaxone DALI Pharma 1 g Powder for Solution for Injection Malta - English - Medicines Authority

ceftriaxone dali pharma 1 g powder for solution for injection

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - ceftriaxone sodium - powder for solution for injection - ceftriaxone sodium 1 g - antibacterials for systemic use

Ceftriaxone 1g powder for solution for injection/infusion Ireland - English - HPRA (Health Products Regulatory Authority)

ceftriaxone 1g powder for solution for injection/infusion

jed pharma limited - ceftriaxone sodium - solution for injection/infusion - ceftriaxone

CEFTRIAXONE-VIT Israel - English - Ministry of Health

ceftriaxone-vit

vitamed pharmaceutical industries ltd - ceftriaxone as disodium hemiheptahydrate - powder for solution for injection - ceftriaxone as disodium hemiheptahydrate 1.0 g/vial - ceftriaxone - ceftriaxone vit is indicated for the treatment of the following infections in adults andchildren including term neonates (from birth):-bacterial meningitis- community acquired pneumonia-hospital acquired pneumonia-acute otitis media-intra-abdominal infections-complicated urinary tract infections (including pyelonephritis)-infections of bones and joints-complicated skin and soft tissue infections-gonorrhoea-syphilis-bacterial endocarditisceftriaxone vit may be used:- for treatment of acute exacerbations of chronic obstructive pulmonary diseasein adults- for treatment of disseminated lyme borreliosis (early (stage ii) and late (stageiii) in adults and children including neonates from 15 days of age.- for pre-operative prophylaxis of surgical site infections-in the management of neutropenic patients with fever that is suspected to be dueto a ceftriaxone – susceptible bacterial infection- in the treatment of patients with bacteraemia that occurs in association with, oris suspected to be associated with, any of the infections listed aboveceftriaxone vit should be co-administered with other antibacterial agents whenever thepossible range of causative bacteria would not fall within its spectrum.

CEFTRIAXONE - TRIMA 1G Israel - English - Ministry of Health

ceftriaxone - trima 1g

trima israel pharmaceutical products maabarot ltd - ceftriaxone as sodium - powder for solution for inj/inf - ceftriaxone as sodium 1 g/vial - ceftriaxone - ceftriaxone is indicated for the treatment of the following infections in adults and children including term neonates (from birth): - bacterial meningitis - community acquired pneumonia - hospital acquired pneumonia - acute otitis media - intra-abdominal infections - complicated urinary tract infections (including pyelonephritis) - infections of bones and joints - complicated skin and soft tissue infections - gonorrhoea - syphilis - bacterial endocarditis ceftriaxone may be used: - for treatment of acute exacerbations of chronic obstructive pulmonary disease in adults - for treatment of disseminated lyme borreliosis (early (stage ii) and late (stage iii) in adults and children including neonates from 15 days of age. - for pre-operative prophylaxis of surgical site infections - in the management of neutropenic patients with fever that is suspected to be due to a ceftriaxone - susceptible bacterial infection - in the treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above ceftriaxone should be co-administered with other antibacterial agents whenever the possible range of causative bacteria would not fall within its spectrum. consideration should be given to official guidelines on the appropriate use of antibacterial agents.

Ceftriaxone 1 g powder for solution for injection/infusion Ireland - English - HPRA (Health Products Regulatory Authority)

ceftriaxone 1 g powder for solution for injection/infusion

as kalceks - ceftriaxone sodium - powder for solution for injection/infusion - third-generation cephalosporins; ceftriaxone

Ceftriaxone 2 g powder for solution for injection/infusion Ireland - English - HPRA (Health Products Regulatory Authority)

ceftriaxone 2 g powder for solution for injection/infusion

as kalceks - ceftriaxone sodium - powder for solution for injection/infusion - third-generation cephalosporins; ceftriaxone